Ojha, J
Secreto, C
Rabe, K
Ayres-Silva, J
Tschumper, R
Dyke, D V
Slager, S
Fonseca, R
Shanafelt, T
Kay, N
Braggio, E
Article History
First Online: 18 July 2014
Competing interests
: RF has received a patent for the prognostication of MM based on genetic categorization of the disease. He has received consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS, Lilly, Onyx, Binding Site, Millenium and AMGEN. He also has sponsored research from Cylene and Onyx. TS was supported by fundings from Hospira, Genentech, Glaxo-Smith-Kline, Jannsen, Celgene and Cephalon. The remaining authors declare no conflcit of interest.